Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yu-Wen Li

Showing results (41-50 of 75) with videos related to

Pageof 8
Sort By:
Journal of Digestive Diseases|January 27, 2015
The -A2518G polymorphism in the MCP-1 gene and inflammatory bowel disease risk: A meta-analysisYu Wen Li, Ci Qiu Yang, Ying Lian Xiao, et al.
Journal of Psychopharmacology (Oxford, England)|January 31, 2018
Mapping the central effects of (±)-ketamine and traxoprodil using pharmacological magnetic resonance imaging in awake ratsHaiying Tang, Daniel Kukral, Yu-Wen Li, et al.
Neuropharmacology|November 24, 2012
Pharmacological and behavioral characterization of the novel CRF1 antagonist BMS-763534Nicholas J Lodge, Snjezana Lelas, Yu-Wen Li, et al.
Bioorganic & Medicinal Chemistry Letters|May 21, 2010
5-arylamino-1,2,4-triazin-6(1H)-one CRF1 receptor antagonistsWilliam D Schmitz, Allison B Brenner, Joanne J Bronson, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 30, 2019
Target Engagement of a Phosphodiesterase 2A Inhibitor Affecting Long-Term Memory in the RatGuibao Gu, Trevor Scott, Yingzhuo Yan, et al.
Journal of Ethnopharmacology|February 22, 2015
Insulinotropic effect of Chikusetsu saponin IVa in diabetic rats and pancreatic β-cellsJia Cui, Miao-Miao Xi, Yu-Wen Li, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 22, 2003
Pharmacological characterization of a novel nonpeptide antagonist radioligand, (+/-)-N-[2-methyl-4-methoxyphenyl]-1-(1-(methoxymethyl) propyl)-6-methyl-1H-1,2,3-triazolo[4,5-c]pyridin-4-amine ([3H]SN003) for corticotropin-releasing factor1 receptorsGe Zhang, Ning Huang, Yu-Wen Li, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 21, 2007
Ex vivo occupancy of gamma-secretase inhibitors correlates with brain beta-amyloid peptide reduction in Tg2576 miceMargi E Goldstein, Yang Cao, Tracey Fiedler, et al.
Neuropharmacology|March 19, 2017
[<sup>3</sup>H]BMT-046091 a potent and selective radioligand to determine AAK1 distribution and target engagementJustin V Louis, Yifeng Lu, Rick Pieschl, et al.
Brain, Behavior, and Immunity|July 13, 2014
Bacillus Calmette-Guérin vaccine induces a selective serotonin reuptake inhibitor (SSRI)-resistant depression like phenotype in miceK Vijaya Kumar, Anjuman Rudra, M V Sreedhara, et al.
Pageof 8

Showing results (41-50 of 75) with videos related to

Sort By:
Pageof 8
Journal of Digestive Diseases|January 27, 2015
The -A2518G polymorphism in the MCP-1 gene and inflammatory bowel disease risk: A meta-analysisYu Wen Li, Ci Qiu Yang, Ying Lian Xiao, et al.
Journal of Psychopharmacology (Oxford, England)|January 31, 2018
Mapping the central effects of (±)-ketamine and traxoprodil using pharmacological magnetic resonance imaging in awake ratsHaiying Tang, Daniel Kukral, Yu-Wen Li, et al.
Neuropharmacology|November 24, 2012
Pharmacological and behavioral characterization of the novel CRF1 antagonist BMS-763534Nicholas J Lodge, Snjezana Lelas, Yu-Wen Li, et al.
Bioorganic & Medicinal Chemistry Letters|May 21, 2010
5-arylamino-1,2,4-triazin-6(1H)-one CRF1 receptor antagonistsWilliam D Schmitz, Allison B Brenner, Joanne J Bronson, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 30, 2019
Target Engagement of a Phosphodiesterase 2A Inhibitor Affecting Long-Term Memory in the RatGuibao Gu, Trevor Scott, Yingzhuo Yan, et al.
Journal of Ethnopharmacology|February 22, 2015
Insulinotropic effect of Chikusetsu saponin IVa in diabetic rats and pancreatic β-cellsJia Cui, Miao-Miao Xi, Yu-Wen Li, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 22, 2003
Pharmacological characterization of a novel nonpeptide antagonist radioligand, (+/-)-N-[2-methyl-4-methoxyphenyl]-1-(1-(methoxymethyl) propyl)-6-methyl-1H-1,2,3-triazolo[4,5-c]pyridin-4-amine ([3H]SN003) for corticotropin-releasing factor1 receptorsGe Zhang, Ning Huang, Yu-Wen Li, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 21, 2007
Ex vivo occupancy of gamma-secretase inhibitors correlates with brain beta-amyloid peptide reduction in Tg2576 miceMargi E Goldstein, Yang Cao, Tracey Fiedler, et al.
Neuropharmacology|March 19, 2017
[<sup>3</sup>H]BMT-046091 a potent and selective radioligand to determine AAK1 distribution and target engagementJustin V Louis, Yifeng Lu, Rick Pieschl, et al.
Brain, Behavior, and Immunity|July 13, 2014
Bacillus Calmette-Guérin vaccine induces a selective serotonin reuptake inhibitor (SSRI)-resistant depression like phenotype in miceK Vijaya Kumar, Anjuman Rudra, M V Sreedhara, et al.
Pageof 8